Mouse Anti-MAP3K20 Recombinant Antibody (3F11) (CBMAB-A10001-LY)

Name: Mouse Anti-MAP3K20 Recombinant Antibody (3F11)
SKU: CBMAB-A10001-LY
Rating: 5 (1 reviews)

See all MAP3K20 antibodies

Compare Online Inquiry

Datasheet

SDS

Request for COA

Datasheet Target References Q & As Review & reward Protocols Associated Products

Basic Information

Host Animal

Mouse

Clone

3F11

Application

WB, ELISA

Immunogen

ZAK (AAH01401, 1 a.a. ~ 120 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.

Specificity

Human

Antibody Isotype

IgG2a, κ

Clonality

Monoclonal

Application Notes

The COA includes recommended starting dilutions, optimal dilutions should be determined by the end user.

Formulations & Storage [For reference only, actual COA shall prevail!]

Format

Liquid

Purity

> 95% Purity determined by SDS-PAGE.

Storage

Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freezethaw cycles.

More Infomation

Target

Full Name

Mitogen-Activated Protein Kinase Kinase Kinase 20

Introduction

This gene is a member of the MAPKKK family of signal transduction molecules and encodes a protein with an N-terminal kinase catalytic domain, followed by a leucine zipper motif and a sterile-alpha motif (SAM). This magnesium-binding protein forms homodimers and is located in the cytoplasm. The protein mediates gamma radiation signaling leading to cell cycle arrest and activity of this protein plays a role in cell cycle checkpoint regulation in cells. The protein also has pro-apoptotic activity. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq]

Entrez Gene ID

51776

UniProt ID

Q9NYL2

Alternative Names

AZK; MLK7; MLT; MLTK; MRK; mlklak

Function

Stress-activated component of a protein kinase signal transduction cascade. Regulates the JNK and p38 pathways. Part of a signaling cascade that begins with the activation of the adrenergic receptor ADRA1B and leads to the activation of MAPK14. Pro-apoptotic. Role in regulation of S and G2 cell cycle checkpoint by direct phosphorylation of CHEK2 (PubMed:10924358, PubMed:11836244, PubMed:15342622, PubMed:21224381).
Involved in limb development (PubMed:26755636).
Isoform 1
Phosphorylates histone H3 at 'Ser-28' (PubMed:15684425).
May have role in neoplastic cell transformation and cancer development (PubMed:15172994).
Causes cell shrinkage and disruption of actin stress fibers (PubMed:11042189).

Biological Process

Cell cycleIEA:UniProtKB-KW
Cell death1 PublicationNAS:UniProtKB
Cell differentiation1 PublicationNAS:UniProtKB
Cellular response to gamma radiationManual Assertion Based On ExperimentIDA:UniProtKB
Cytoskeleton organizationIEA:Ensembl
DNA damage checkpoint signalingManual Assertion Based On ExperimentIMP:UniProtKB
Embryonic digit morphogenesisManual Assertion Based On ExperimentIMP:UniProtKB
JNK cascadeManual Assertion Based On ExperimentIDA:UniProtKB
Limb developmentManual Assertion Based On ExperimentIMP:UniProtKB
p38MAPK cascadeManual Assertion Based On ExperimentIDA:UniProtKB
Positive regulation of apoptotic processManual Assertion Based On ExperimentIDA:UniProtKB
Positive regulation of mitotic DNA damage checkpointManual Assertion Based On ExperimentIDA:UniProtKB
Protein phosphorylationManual Assertion Based On ExperimentIDA:UniProtKB
Stress-activated MAPK cascadeManual Assertion Based On ExperimentIDA:UniProtKB

Cellular Location

Cytoplasm
Nucleus
Translocates to the nucleus upon ultraviolet B irradiation.

Involvement in disease

Split-foot malformation with mesoaxial polydactyly (SFMMP):
An autosomal recessive disorder characterized by a split-foot defect, mesoaxial polydactyly, nail abnormalities of the hands, and sensorineural hearing loss.
Myopathy, centronuclear, 6, with fiber-type disproportion (CNM6):
A form of centronuclear myopathy, a congenital muscle disorder characterized by progressive muscular weakness and wasting involving mainly limb girdle, trunk, and neck muscles. It may also affect distal muscles. Weakness may be present during childhood or adolescence or may not become evident until the third decade of life. Ptosis is a frequent clinical feature. The most prominent histopathologic features include high frequency of centrally located nuclei in muscle fibers not secondary to regeneration, radial arrangement of sarcoplasmic strands around the central nuclei, and predominance and hypotrophy of type 1 fibers. CNM6 is an autosomal recessive, slowly progressive form with onset in infancy or early childhood.

Ahmad, I., Khan, A., Noor Ul Ayan, H., Budde, B., Altmüller, J., Korejo, A. A., ... & Erdmann, J. (2023). A novel MAP3K20 mutation causing centronuclear myopathy-6 with fiber-type disproportion in a Pakistani family. Journal of human genetics, 68(2), 107-109.

Rosenfeld, J., Shealy, A., Eble, T., Burrage, L., Liu, P., Moran, R., ... & Lalani, S. (2022). eP223: Dominant-acting MAP3K20 variants cause split-foot malformation and sensorineural hearing loss. Genetics in Medicine, 24(3), S138-S139.

Ask a question We look forward to hearing from you.

0 reviews or Q&As

Purchasing FAQs
Technical FAQs

Have you used Mouse Anti-MAP3K20 Recombinant Antibody (3F11)?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon

$30 eGift Card
Submit a review

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme-Linked Immunospot (ELISpot)
Proteogenomics
Other Protocols

Related Products

Mouse Anti-MAP3K20 Recombinant Antibody (CBXS-1006) (CAT#: CBMAB-S3908-CQ)

Mouse Anti-MAP3K20 Recombinant Antibody (3G5) (CAT#: CBMAB-A10002-LY)

Mouse Anti-MAP3K20 Recombinant Antibody (3B6) (CAT#: CBMAB-A9999-LY)

Mouse Anti-MAP3K20 (AA 1-456) Recombinant Antibody (CBFYM-1523) (CAT#: CBMAB-M1686-FY)

Mouse Anti-MAP3K20 Recombinant Antibody (2G7) (CAT#: CBMAB-A9998-LY)

Mouse Anti-MAP3K20 Recombinant Antibody (3D11) (CAT#: CBMAB-A10000-LY)

Rabbit Anti-MAP3K20 Recombinant Antibody (CBWJZ-012) (CAT#: CBMAB-Z0019-WJ)

Mouse Anti-MAP3K20 Recombinant Antibody (1D5) (CAT#: CBMAB-A9997-LY)

Mouse Anti-MAP3K20 Recombinant Antibody (CBXS-1005) (CAT#: CBMAB-S3907-CQ)

Mouse Anti-MAP3K20 Recombinant Antibody (4C4) (CAT#: CBMAB-A10003-LY)

Isotype control

For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Online Inquiry

Request bulk or custom quote Second antibody and isotype control

Contact us

Tel: (USA)
(UK)
Fax:

Global Locations

Email:

Online Inquiry